CooperCompanies Completes Strategic Review, Expands Buyback to $3B, Posts Q3 Beat
COO is trading near its 52-week low of $58.89 (7.5% below the low) on elevated volume (3.8× avg).
Summary
CooperCompanies reported Q3 revenue of $1.066 billion (up 1% y/y) and non-GAAP EPS of $1.15, completed its strategic review by retaining CooperSurgical, and expanded its share repurchase authorization from $2 billion to $3 billion.
Key Events · Earnings and Guidance · COO
-
Q3 Revenue Misses, EPS Beats
Revenue of $1.066 billion rose 1% y/y but missed the $1.10 billion consensus; non-GAAP diluted EPS of $1.15 beat expectations, up 4% y/y.
-
Strategic Review Concludes: Keep CooperSurgical
Board unanimously decided to retain CooperSurgical after evaluating a sale, citing a valuation disconnect from offers received due to competitive and litigation factors.
-
Buyback Authorization Expanded to $3B
Board increased the share repurchase authorization from $2 billion to $3 billion; approximately $1.5 billion remains available after $339.1 million repurchased in Q3.
-
$307.2M One-Time Tax Benefit
Favorable completion of a U.K. tax examination produced a $307.2 million discrete tax benefit, driving GAAP diluted EPS to $2.24 versus $0.49 a year ago.
Analysis · COO · Industrial Applications And Services
CooperCompanies delivered a mixed quarter — revenue missed consensus but non-GAAP EPS beat — while resolving a months-long strategic review by deciding to keep CooperSurgical and expanding its buyback authorization by $1 billion. The $307.2 million tax benefit is a one-time windfall that flatters GAAP results but does not reflect operating performance. The board's decision to retain CooperSurgical after evaluating a sale signals confidence in the business, but the disclosed 'valuation disconnect' from offers suggests bidders saw less value than management. The expanded buyback, with $1.5 billion remaining, gives management a tool to support the stock near its 52-week low.
How filings like this one have moved
In the 30 days to Sep 9, 2026, 36.4% of the 1919 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, COO was trading at $54.49 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $12.4B. The 52-week trading range was $58.89 to $89.83. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.